2010
DOI: 10.1111/j.1365-2982.2010.01598.x
|View full text |Cite
|
Sign up to set email alerts
|

Expression and activation of β-adrenoceptors in the colorectal mucosa of rat and human

Abstract: β₁- and β₂-adrenoceptors are predominantly expressed in the colorectal mucosa. Perturbation of endogenous catecholamine levels influences the expression and activation of β-adrenoceptors in the colorectal region.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(9 citation statements)
references
References 37 publications
(57 reference statements)
0
9
0
Order By: Relevance
“…Of note, propranolol also produced a significant reduction in energy expenditure in the S-5AA, S-5AA+Met, and S-16AA-Met. Because 6-OHDA treatment increases the protein abundance of β1 and β2-AR in the colon with enhanced sensitivity to dopamine and norepinephrine to colonic ion transport [59], it is likely that the upregulation of peripheral β1 and β2-AR contributed to the robust effects of propranolol on energy expenditure in 6-OHDA-treated rats. Alternatively, it is also likely that 6-OHDA was ineffective in producing a total ablation of noradrenergic nerve terminals with the subsequent recovery of β-adrenergic signaling over the 3-week course of the study.…”
Section: Discussionmentioning
confidence: 99%
“…Of note, propranolol also produced a significant reduction in energy expenditure in the S-5AA, S-5AA+Met, and S-16AA-Met. Because 6-OHDA treatment increases the protein abundance of β1 and β2-AR in the colon with enhanced sensitivity to dopamine and norepinephrine to colonic ion transport [59], it is likely that the upregulation of peripheral β1 and β2-AR contributed to the robust effects of propranolol on energy expenditure in 6-OHDA-treated rats. Alternatively, it is also likely that 6-OHDA was ineffective in producing a total ablation of noradrenergic nerve terminals with the subsequent recovery of β-adrenergic signaling over the 3-week course of the study.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, dopaminergic blockers (domperidone, for example) are used as GI prokinetics, as they antagonize DA inhibitory effects on GI motility, by blocking DRD2 . A further element of complexity is added by the observation that, in the GI, DA is able to activate adrenergic (alpha and beta) receptors to modulate, for example, motility in the small intestine and ion transport in the distal colon …”
Section: Discussionmentioning
confidence: 99%
“…With DRD2 being blocked by L‐741626, overabundant endogenous DA may have activated alternative, non‐dopaminergic receptors, causing peristalsis inhibition. Indeed, various studies have shown that DA can activate beta‐adrenergic receptors in various GI segments, including the distal colon and activation of beta‐adrenergic receptors is associated with muscle relaxation . Moreover, it has been reported that L‐741626, while blocking DRD2, can enhance DA release, for example in the striatum of rats or in the guinea‐pig cochlea .…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, the presence of mRNA for β1/2/3‐AR in rat vaginal epithelium and β1/2‐AR in VK2E6E7 cells were indentified. As epithelial β3‐AR is neither expressed in VK2/E6E7 cells nor involved in ion transport [40], the β1/2‐AR protein expression was examined by Western blot and immunofluorescence. The observations above suggested that the epithelial β1‐AR and β2‐AR are both expressed in vaginal epithelium and involved in mediating adrenaline‐induced Cl − secretion.…”
Section: Discussionmentioning
confidence: 99%